Australia's largest stock trading and investment forum Australia's #1 stock forum

IHL

Click for more information

0.00%

4.1¢ incannex healthcare limited

I posted similar screenshots in the US listing thread not seeing...

First 8244 Last

ma420

7,255 Posts.

1847

28/09/21

23:02

Post #: 56418946

Originally posted by malkazoid: ↑
"In particular, we estimate that such funds, together with such existing cash, will be sufficient to enable us to advance our
clinical trials to the point where all programs have completed pivotal Phase 2 trials or two programs have
completed pivotal Phase 2 trials and one program completed a Phase 3 clinical trial. The specifics of which
trials are progressed first will depend on clinical success. At this stage we anticipate that the OSA, RA and IBD
will advance the quickest. Funds for additional Phase 3 trials will be raised through future capital raises. It is
estimated that completion of all six clinical development programs will cost approximately A$200 million."

-------------------

I love this part.
Confirmation that OSA, Rheumatoid Arthritis and IBD will probably push through the stages fastest. I suspected RA would go quickly considering IHL675a is basically a vastly improved version of an existing approved and standard treatment for the affliction.

Also great to see a ballpark cost for all trials. I have full confidence they will find ample funding for these along the way: investors and potential partners will take note of the massive market potential and de-risked nature of these pathways.
Expand

Originally posted by thevinnys: ↑
NEW PATENTS UPDATES

Major Change here in the Amended Filing
As of 20 September, 2021, we added 5 new patent applications to our portfolio: PCT/AU2020/051056, PCT/AU2021/050226, PCT/AU2021/050734, Australian Provisional Patent Application No. AU 2021902170, and Australian Provisional Patent Application No. AU 2021902426.
Patent Portfolio
The following table presents our portfolio of patents and patent applications, including their status (as at 20 September, 2021) and title.
Patent Family
Title
Status
Expires
1
PCT/AU2020/051056
Compositions for the treatment or prevention of traumatic brain injury
Pending
02/10/2040*
2
PCT/AU2021/050226
Methods and compositions for treating or preventing an inflammatory condition
Pending
15/03/2041*
3
PCT/AU2021/050734
Compositions and methods for the treatment of obstructive sleep apnoea (OSA)
Pending
09/07/2041*
4
AU 2021902170
A composition and uses thereof
Pending (Provisional)
14/07/2042^*
5
AU 2021902426
A method of treatment
Pending (Provisional)
04/08/2042^*

Complete new update from original filing
Expand
I posted similar screenshots in the US listing thread not seeing this before. Good luck guys.

IHL Price at posting: 36.0¢ Sentiment: Buy Disclosure: Held

0 Great analysis

Top Stories

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

Making money: How many microcaps should be in an investor's portfolio?

Bitcoin hits fresh record as instos pile into BTC ETFs – and Trump helps, too

Aussie inflation seemingly hit a 3 year low. So why's the ASX200 red?

The Altcoin Landscape (Part 1): Key alternative cryptocurrencies to watch

There are more pages in this discussion • 12,201 more messages in this thread...

First 8244 Last

Add IHL (ASX) to my watchlist